Semax 10MG

SEMAX | Neurocognitive Research Peptide

Exploring the Science of Brain Signaling & Neuroprotection

Semax is a synthetic heptapeptide derived from the ACTH(4–10) sequence that has been studied for its potential effects on neurological signaling, cognitive processes, and neuroprotective pathways. Research has explored Semax in connection with attention and memory, neurotrophic signaling, oxidative stress, and responses to neurological injury.

Preclinical and clinical research has investigated Semax in several neurological settings, although evidence varies by application and much of the modern research remains limited. Recent preclinical work has continued examining potential mechanisms involving neuroinflammation and cellular stress responses.

Research Focus

• Cognitive and neurobehavioral research
• Neuroprotective signaling
• Neurotrophic pathways
• Oxidative-stress research
• Neuroinflammation
• Brain and nervous-system biology

Research Status: Investigational in the United States. FDA materials identify potential concerns for compounded Semax, including immunogenicity and peptide-related impurities.

Research use only.